Search results
Eosinopenia is defined as an absolute eosinophil count of less than 0.09 × 10 9 /L and can be difficult to detect because the reference interval is low. Eosinopenia often accompanies other cytopenias in conditions that result in marrow hypoplasia, specifically involving leukocytes.
24 maj 2021 · Eosinopenia has been identified as a potential biomarker of sepsis in the past decade. However, its clinical application progress is slow and its recognition is low. Recent studies have again focused on the potential association between Eosinopenia and severe infections.
Eosinopenia is associated with several disease states and conditions, including inflammation and sepsis, endogenous catecholamines, and use of glucocorticoids. [1] There are also medications that deliberately target eosinophils in order to treat eosinophil-mediated diseases, causing drug-induced eosinopenia.
24 kwi 2008 · We assessed the value of eosinopenia as marker of sepsis by comparing the eosinophil cell count between noninfected patients (negative, SIRS) and infected patients (sepsis, severe sepsis, and septic shock), and between SIRS patients and infected patients on the day of admission to the ICU.
3 mar 2011 · As a cheap test for early identification of critically ill patients at high risk of mortality on admission to ICU, eosinopenia might aid physicians in their initial decisions, and help to identify patients who may require more aggressive diagnostic and therapeutic interventions.
14 cze 2022 · Results. A total of 149 children were included in which 7.4% (11) cases with eosinopenia and 52.3% (78) cases with sepsis. Septic patients with eosinopenia had a mortality rate 33.3% less than patients without eosinopenia at 43.2%. There was no significant difference, p= 0.731.
5 lip 2024 · The key finding of this study was an association between blood eosinopenia (≤50/μL) and an increase in in-hospital mortality, need for mechanical ventilation, risk of sepsis, length of stay in survivors, and reduced time to in-hospital death in a real-world patient cohort.
